How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Consumer Goods · Forecast 2027–2033
Performance Insoles Market
- By Product Type: Gel Insoles, Foam Insoles, Carbon Fiber Insoles, EVA Insoles, Orthotic Insoles
- By Application: Sports Performance, Medical/Orthopedic, Casual Wear, Work Safety, Military and Tactical
- By End User: Athletes, Fitness Enthusiasts, Patients with Foot Disorders, Workers in Industrial Jobs, Military Personnel
- By Material: Silicone, Polyurethane, EVA (Ethylene Vinyl Acetate), Carbon Fiber, Memory Foam
- By Distribution Channel: Online Retail, Specialty Sports Stores, Pharmacies and Medical Stores, Department Stores, Direct-to-Consumer
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Gel Insoles leads By Product Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 305 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.186 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.194 →
Full report · locked preview
Everything inside the Performance Insoles Market report
A complete, evidence-based study - 12 chapters and 128 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Product Type 5
Application 5
End User 5
Material 5
Distribution Channel 5
Companies profiled
Dr. Scholl's (Bayer AG)
Superfeet Worldwide Inc.
Sidas
Spenco Medical Corporation
SOLE
Powerstep
Birkenstock Group
Vionic Group
Tread Labs
FootBalance
Pedag International
OrthoStep
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Dr. Scholl's (Bayer AG)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Superfeet Worldwide Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Sidas
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Spenco Medical Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →SOLE
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Powerstep
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Birkenstock Group
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Vionic Group
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Tread Labs
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →FootBalance
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Pedag International
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →OrthoStep
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Protalus
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Currex
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Aetrex Worldwide
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$7,219M by 2033 · 11.3% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Gel Insoles56.9
- Foam Insoles7.2
- Carbon Fiber Insoles16.8
- EVA Insoles6.9
- Orthotic Insoles12.1
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,012M → $2,442M · 11.6%
Europe$705.2M → $1,700M · 11.6%
Asia Pacific$643.9M → $1,667M · 12.6%
Latin America$398.6M → $963.4M · 11.7%
Middle East and Africa$306.6M → $799.6M · 12.7%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →11.252026
11.262027
11.272028
11.292029
11.302030
11.312031
11.322032
11.332033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Dr. Scholl's (Bayer AG)12.3
- Superfeet Worldwide Inc.23.8
- Sidas4.9
- Spenco Medical Corporation9.8
- SOLE11.3
- Powerstep9.9
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Type26.9%
Application9.4%
End User18.3%
Material18.6%
Distribution Channel26.7%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America32.2
- Europe22.5
- Asia Pacific22.0
- Latin America12.7
- Middle East and Africa10.6
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Dr. Scholl's (Bayer AG) | 78 | 80 | 86 | 86 | 97 | 74 | 84 |
| Superfeet Worldwide Inc. | 86 | 86 | 72 | 84 | 91 | 73 | 82 |
| Sidas | 63 | 70 | 71 | 83 | 69 | 71 | 71 |
| Spenco Medical Corporation | 70 | 82 | 63 | 67 | 73 | 67 | 70 |
| SOLE | 59 | 52 | 54 | 70 | 70 | 77 | 64 |
| Powerstep | 68 | 48 | 56 | 61 | 69 | 70 | 62 |
| Birkenstock Group | 45 | 46 | 50 | 62 | 40 | 54 | 50 |
| Vionic Group | 50 | 59 | 36 | 42 | 44 | 54 | 48 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Dr. Scholl's (Bayer AG)
- Superfeet Worldwide Inc.
- Sidas
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Dr. Scholl's (Bayer AG) | ◐ | ◐ | ◐ | ✓ | ✓ | ✓ |
| Superfeet Worldwide Inc. | ✓ | ✓ | ◐ | ◐ | ✓ | ◐ |
| Sidas | ◐ | ✓ | ◐ | ✓ | ✓ | ◐ |
| Spenco Medical Corporation | ◐ | ◐ | − | − | ◐ | ◐ |
| SOLE | − | ◐ | ◐ | ✓ | ◐ | ✓ |
| Powerstep | ◐ | ◐ | − | − | ◐ | − |
| Birkenstock Group | − | − | − | ◐ | − | − |
| Vionic Group | ◐ | − | − | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Dr. Scholl's (Bayer AG)84
2Superfeet Worldwide Inc.82
3Sidas71
4Spenco Medical Corporation70
5SOLE64
6Powerstep62
7Birkenstock Group50
8Vionic Group48
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Dr. Scholl's (Bayer AG)Superfeet Worldwide Inc.
Challenger2
Strong scale, closing on the leaders.
SidasSpenco Medical Corporation
Contender2
Focused players with pockets of strength.
SOLEPowerstep
Niche2
Specialists in a single segment or region.
Birkenstock GroupVionic Group
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Product Type in North America, then scale across Performance Insoles Market — a $506M beachhead inside a $7.04B market.
Beachhead (SOM)$506Mobtainable near-term
Serviceable (SAM)$2.68Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion91 fit
Gel Insoles
Best fit — highest urgency & budget in Product Type.
Economic buyer81 fit
Foam Insoles
Strong fit — clear ROI and a fast path to value.
End user66 fit
Carbon Fiber Insoles
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Application & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales43%
Partner / channel26%
Digital / self-serve21%
Marketplaces9%
Positioning & messaging
§GTM 2 · p.194 →For Product Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Performance Insoles Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified45%
Sales qualified21%
Evaluation13%
Closed-won8%
$13.7KCAC
$67KLTV
4.9:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Performance Insoles Market is a durable-growth opportunity — $5.83B by 2033, compounding at 8.0%.
TAM · 2025$3.15Btoday
TAM · 2033$5.83Bforecast
CAGR8.0%2027–2033
Cumulative$39.4Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$5.83BTotal addressable market
SAM$2.03BServiceable available market
SOM$343MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →8.0% CAGR
Demand compounds through 2033, outpacing GDP across Product Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$5.83BLarge & growingTAM by 2033 at 8.0% CAGR
$2.03BServiceable nowreachable with today’s model
$343MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$4.55BBear5.2% CAGR
$5.83BBase8.0% CAGR
$7.46BBull10.5% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Application optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Performance Insoles Market — a $3.22B market by 2033. Plan: grow share from 9.7% to 15.8%.
Market size · 2033$3.22Btotal addressable
Market CAGR8.5%2027–2033
Target share15.8%from 9.7% today
Revenue ambition$509Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 9.7% | 15.8% | On track |
| Revenue | $295M | $509M | Ahead |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Behind |
| Gross margin | 34.6% | 40.7% | At risk |
| Customer retention | 86.9% | 94.8% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Application capability
A defensible second engine — invest in Application to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Application
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $52M capacity & capability investment
- Greenlight bolt-on M&A in Application
- Authorise North America expansion plan
- Fund R&D program for Product Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAt risk
- Competitive share lossOn track
- Input-cost & supply riskOn track
- Regulatory / policy changeAt risk
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Performance Insoles Market conversation — a $4.01B market you can size, segment and defend in minutes.
Market size · 2033$4.01Btotal opportunity
Growth10.6%CAGR to 2033
Addressable buyers1,404+accounts in scope
Typical ROI5×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Type
Goal Grow share in Product Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →5×return on cost, year one
< 4 mopayback period
$65K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Dr. Scholl's (Bayer AG)Superfeet Worldwide Inc.SidasSpenco Medical CorporationSOLEPowerstepBirkenstock GroupVionic Group+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Performance Insoles Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Performance Insoles Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Consumer Goods · scroll →Boundary-Perimeter Wire Free Robot Lawn Mower Market
Market size, share, segmentation and regional forecast.
$1.2B market · 2025 base year
View reportProfessional Equestrian Helmet Market
Market size, share, segmentation and regional forecast.
$496M market · 2025 base year
View reportEquestrian Riding Gloves Market
Market size, share, segmentation and regional forecast.
$6.1B market · 2025 base year
View reportHousehold Electric Egg Steamer Market
Market size, share, segmentation and regional forecast.
$2.3B market · 2025 base year
View reportHousehold Small Electric Steam Cooker Market
Market size, share, segmentation and regional forecast.
$1.1B market · 2025 base year
View reportMountain Bike Cycling Computer Market
Market size, share, segmentation and regional forecast.
$591M market · 2025 base year
View reportPassenger Car Fragrance Diffuser Market
Market size, share, segmentation and regional forecast.
$5.3B market · 2025 base year
View reportSea Fishing Fluorocarbon Lines Market
Market size, share, segmentation and regional forecast.
$3.5B market · 2025 base year
View reportWhite Duck Down Pillow Market
Market size, share, segmentation and regional forecast.
$2.3B market · 2025 base year
View reportDown Pillow Core Market
Market size, share, segmentation and regional forecast.
$5.3B market · 2025 base year
View reportFlutes Instrument Market
Market size, share, segmentation and regional forecast.
$1.2B market · 2025 base year
View reportIndoor Cycling Exercise Bike Market
Market size, share, segmentation and regional forecast.
$745M market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.